SCHEMBL2774740

SCHEMBL2774740

Nc1c(C(=O)O)oc2ccccc12

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.72
NPC1 O15118 9/20 0.72
KMT2A Q03164 3/20 0.72
KDM4E B2RXH2 7/20 0.65
SMN1; SMN2 Q16637 7/20 0.59
RAB9A P51151 7/20 0.59
AHR P35869 2/20 0.59
TDP1 Q9NUW8 2/20 0.59
POLB P06746 2/20 0.59
ALDH1A1 P00352 3/20 0.55
MEN1 O00255 2/20 0.55
HPGD P15428 2/20 0.55
USP2 O75604 2/20 0.55
CASP1 P29466 2/20 0.55
HCRTR1 O43613 1/20 0.55
TSHR P16473 1/20 0.55
NFKB1 P19838 1/20 0.55
HTT P42858 1/20 0.55
NFKB2 Q00653 1/20 0.55
RELA Q04206 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1006030 0.85 MAPT (0.67) MAPTNPC1KMT2AKDM4ESMN1; SMN2
SCHEMBL429754 0.84 MAPT (1.00) MAPTNPC1KMT2AKDM4ESMN1; SMN2
SCHEMBL30168106 0.83 KDM4E (0.68) MAPTNPC1KMT2AKDM4ESMN1; SMN2
SCHEMBL6857835 0.83 KDM4E (0.68) MAPTNPC1KMT2AKDM4ESMN1; SMN2
SCHEMBL23610605 0.80 NPC1 (0.52) MAPTNPC1KMT2AKDM4ESMN1; SMN2
SCHEMBL13744783 0.80 MAPT (0.60) MAPTNPC1KMT2AKDM4ESMN1; SMN2
SCHEMBL13743910 0.80 NPC1 (0.79) MAPTNPC1KMT2AKDM4ESMN1; SMN2
SCHEMBL3610930 0.79 PTPN1 (0.59) MAPTNPC1KMT2AKDM4ETDP1
SCHEMBL1885241 0.79 KDM4E (1.00) MAPTNPC1KMT2AKDM4ESMN1; SMN2
SCHEMBL13664957 0.79 KDM4E (0.66) MAPTNPC1KMT2AKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020142729-A1 INHIBITORS OF CGAS ACTIVITY AS THERAPEUTIC AGENTS BellBrook Labs (US) 2020-07-09 WO disclosed
CN-108200760-A BENZODIAZEPINE DERIVATIVES AS RSV INHIBITORS 英安塔制药有限公司 2018-06-22 CN disclosed
EP-2699572-A1 HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS Origenis GmbH (DE) 2014-02-26 EP disclosed
EP-2699579-A1 PYRAZOLO [4, 3-D]PYRIMIDINES USEFUL AS KINASE INHIBITORS Origenis GmbH (DE) 2014-02-26 EP disclosed
WO-2012143143-A1 HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS ORIGENIS GMBH (DE) 2012-10-26 WO disclosed
WO-2012143144-A1 PYRAZOLO [4, 3-D] PYRIMIDINES USEFUL AS KINASE INHIBITORS ORIGENIS GMBH (DE) 2012-10-26 WO disclosed
EP-2161266-A1 Benzofuran derivatives as orexin receptor antagonists EVOTEC Neurosciences GmbH (DE) 2010-03-10 EP disclosed
CN-1131418-A Novel fused-ring carboxylic acid compound or salt thereof, and medicinal use thereof GREEN CROSS CORP (JP) 1996-09-18 CN disclosed
EP-0187487-B1 BENZOTHIOPHENES AND BENZOFURANS HAVING ANTIALLERGIC ACTIVITY WARNER-LAMBERT COMPANY (US) 1990-08-29 EP disclosed
US-4703053-A Benzothiophenes and benzofurans and antiallergic use thereof WARNER-LAMBERT COMPANY (US) 1987-10-27 US disclosed
EP-0187487-A1 Benzothiophenes and benzofurans having antiallergic activity WARNER-LAMBERT COMPANY (US) 1986-07-16 EP disclosed